Keyphrases
Chemotherapy
100%
Advanced Hodgkin's Lymphoma
100%
Chemotherapy Alone
100%
Radiotherapy
100%
Confidence Interval
59%
Risk Ratio
36%
Progression-free Survival
36%
Overall Survival
36%
Hazard Ratio
31%
Mortality Risk
27%
Chemotherapy Cycles
22%
High Risk
13%
Review Update
13%
Sensitivity Analysis
13%
Risk of Bias
13%
Randomized Controlled Trial
13%
Chemotherapy Regimen
9%
Disease-specific Mortality
9%
MEDLINE
9%
Cancer Mortality
9%
Conference Proceedings
9%
Second Cancer
9%
Complete Response Rate
9%
Cardiac Disease
9%
Chemotherapy-induced
9%
Infection-related Mortality
9%
Control Arm
9%
Number of Patients
9%
International Symposium
4%
Embase
4%
Hodgkin Lymphoma
4%
Effect Measure
4%
Response Rate
4%
Review Authors
4%
Child-only
4%
Extracted Data
4%
Varying number
4%
Treatment Group
4%
Event-free Survival
4%
Chemotherapy-only
4%
Advanced Stage
4%
Search Methods
4%
Selection Criteria
4%
Secondary Malignancy
4%
Long-term Adverse Effects
4%
New Trial
4%
Combined Modality Therapy
4%
Number of Cycles
4%
Tumor Control
4%
Nursing and Health Professions
Radiotherapy
100%
Hodgkin Disease
100%
Confidence Interval
59%
Overall Survival
36%
Progression Free Survival
36%
Hazard Ratio
31%
Second Cancer
9%
Infection
9%
Heart Disease
9%
Event Free Survival
4%
Treatment Group
4%
Embase
4%
Cancer Control
4%
Systematic Review
4%
Adverse Drug Reaction
4%
Immunology and Microbiology
Progression Free Survival
100%
Overall Survival
100%
Arm
87%
Event Free Survival
12%
Embase
12%
Veterinary Science and Veterinary Medicine
Arm
100%
Hodgkin Lymphoma
100%
Cancer
42%
Infectious Disease
28%
Neoplasm
14%
Pharmacology, Toxicology and Pharmaceutical Science
Hodgkin Disease
100%
Chemotherapy
100%
Progression Free Survival
17%
Overall Survival
17%
Randomized Controlled Trial
6%
Heart Disease
4%
Second Cancer
4%
Infection
4%
Clinical Study
2%
Treatment Group
2%
Adverse Drug Reaction
2%
Neoplasm
2%
Event Free Survival
2%